NCT03145116View on ClinicalTrials.gov

Clinical Safety and Efficacy of CT ASPHINA 509 Lenses

NATerminatedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

September 22, 2017

Primary Completion Date

February 5, 2018

Study Completion Date

February 5, 2018

Conditions
Cataract
Interventions
DEVICE

CT ASPHINA 509

Intraocular lens

Trial Locations (1)

12593

Augenklinink, Ahaus

Sponsors
All Listed Sponsors
lead

Carl Zeiss Meditec AG

INDUSTRY

NCT03145116 - Clinical Safety and Efficacy of CT ASPHINA 509 Lenses | Biotech Hunter | Biotech Hunter